GB5121, a Brain-Penetrant, Irreversible BTK Inhibitor, Demonstrates Potent Anti-Tumor Activity in a Novel Mouse Model of Intracranial Lymphoma

Autor: Yusuf, Isharat *, Steinberg, Marcos W *, Gozo, Maricel *, Clemons, Bryan *, Hou, Kay *, Guimond, David *, Rose, Mark J *, Taylor Meadows, Kristen *, Carter, Laura *
Zdroj: In Blood 15 November 2022 140 Supplement 1:8878-8879
Databáze: ScienceDirect